Omixon is a global molecular diagnostics company, empowering clinical labs with technologies to improve patient outcomes by commercializing disruptive innovations specializing in targeted applications for Next Generation Sequencing (NGS). The Omixon Holotype HLA™ product combines a targeted HLA Assay and the Omixon HLA Twin™ software to deliver the most accurate high-resolution HLA genotyping available. Omixon maintains an active grant-funded research program and assists scientists and clinicians to analyze the most challenging genomic regions including HLA, KIR and ABO.
Designing an Experiment Designing a validation study for any kind of tool can be a great challenge. For cutting edge technology, this challenge can be even greater. In this blog post I’ll try to cover some problematic aspects and methodological …more
Thank you to all our wonderful customers, co-vendors and distributors for visiting our booth joining our events and just generally hanging out in the sun, by the pool, or in the bar or over coffee at the 30th annual EFI meeting …more